NA
GH icon

Navellier & Associates’s Guardant Health GH Stock Holding History

Navellier & Associates’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$485K Sell
5,254
-158
-3% -$15.9K 0.05% 217
2025
Q4 		$553K Sell
5,412
-2,342
-30% -$210K 0.06% 208
2025
Q3 		$484K Buy
+7,754
New +$422K 0.05% 262

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Navellier & Associates's GH Position: Q1 2026 in Review

Navellier & Associates reduced its Guardant Health (GH) stake by 2.9% in Q1 2026, selling an estimated $15.9K and leaving 5,254 shares worth $485K. The position accounts for 0.05% of the portfolio, ranked #217.

Navellier & Associates first reported a position in GH in Q3 2025 and has held it in 3 quarters since. The position peaked at $553K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Navellier & Associates held 5,254 shares of Guardant Health worth $485K as of Q1 2026.
  • Navellier & Associates sold 158 Guardant Health shares in Q1 2026, an estimated $15.9K.
  • Guardant Health made up 0.05% of Navellier & Associates's portfolio in Q1 2026, its #217 holding.
  • Navellier & Associates first reported a position in Guardant Health in Q3 2025 and has held it in 3 quarters since.
  • Navellier & Associates's Guardant Health position peaked at $553K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.